PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease SALT LAKE CITY, UT, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- PhotoPharmics, Inc. today announced the peer-reviewed publication of results …